Top FDA drug regulator plans to depart weeks into job
The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…
Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal
Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…
Health-Care Earnings Top S&P 500 on Strong Drug, Hospital Demand
The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty…
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants’ Stocks?
Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…
European Obesity Stocks Join Healthcare Rally as AI Trade Ebbs
European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from…
FDA’s plan to boost cheaper copycat drugs could stall at the patent office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis,…
FDA Unveils New Path for Approving Drugs for Just One Patient
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring…
FDA Chaos Threatens US Biomedical Innovation and Patients Health
The US Food and Drug Administration under a second Trump administration is mired in discord, acrimony and chaos…
FDA Pulls Warning Labels From Hormone Replacement Therapies
Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about some potential…
Now That There’s Deal to End the Shutdown, Here’s What to Expect Next
This is Washington Edition, the newsletter about money, power and politics in the nation’s capital. Every Monday, Bloomberg…